Item 2.02 Results of Operations and Financial Condition

On July 07, 2021, Biotricity, Inc. (the "Company") issued a press release reporting certain unaudited financial results for the 2022 fiscal first quarter, ended June 30, 2021 and providing certain guidance. The full text of this press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

Pursuant to General Instruction B.2. to Form 8-K, the information set forth in this Item 2.02 and Exhibit 99.1 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall any of them be incorporated by reference in any filing under the Securities Act of 1933, as amended or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits. The exhibit listed in the following Exhibit Index is furnished as part of this Current Report on Form 8-K:





Exhibit
Number    Description
99.1        Press Release dated July 07, 2021




2

© Edgar Online, source Glimpses